| RS546729596 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS546732114 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Inborn genetic diseases |
| RS546735701 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, ALDOB-related disorder |
| RS546737191 |
PNPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxal phosphate-responsive seizures, Inborn genetic diseases |
| RS546741834 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Cardiovascular phenotype |
| RS546742857 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Iron accumulation in brain, Infantile neuroaxonal dystrophy |
| RS546747242 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS546751789 |
LIAS
|
Health Risk |
Likely pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS546757986 |
LMNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546761850 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 1, Familial hyperinsulinism |
| RS546764418 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Fraser syndrome 1 |
| RS546776797 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica inversa, autosomal recessive |
| RS546788276 |
C6
|
Health Risk |
Likely pathogenic |
— |
| RS546799731 |
DDX59
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome V, Orofaciodigital syndrome V |
| RS546802775 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS546805063 |
TCTN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 18, Orofacial-digital syndrome IV |
| RS546812521 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
Houge-Janssens syndrome 2, Neoplasm |
| RS546816780 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Susceptibility to mononeuropathy of the median nerve, mild |
| RS546817580 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS546820887 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS546821182 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS546825674 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized juvenile polyposis/juvenile polyposis coli, Generalized juvenile polyposis/juvenile polyposis coli |
| RS546831778 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546841812 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546845105 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS546849670 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Sick sinus syndrome 1, Brugada syndrome 1 |
| RS546851135 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS546856641 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII deficiency, Congenital factor VII deficiency |
| RS546865056 |
MED13L
|
Health Risk |
Likely pathogenic |
— |
| RS546865410 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS546869744 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS546871592 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS546878201 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS546888007 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS546890057 |
CRYGC
|
Health Risk |
Conflicting classifications of pathogenicity |
Nuclear pulverulent cataract, Inborn genetic diseases |
| RS546890576 |
ALG3
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS546892762 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS546898924 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS546902024 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group D |
| RS546902674 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS546905091 |
PRKDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DNA-PKcs deficiency, PRKDC-related disorder |
| RS546906441 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS546908184 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS546924823 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS546927781 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS546932016 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS546933529 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS546939043 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS546939045 |
SLC12A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 34 |
| RS546948362 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cataract 41 |
| RS546957016 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS546966892 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS546968533 |
ATP8A2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS546979072 |
LPIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoglobinuria, acute recurrent |
| RS546988105 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS546988577 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS546989392 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 5 |
| RS546991789 |
FHOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546995952 |
FASN
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS546999572 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS547000637 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS547005691 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Cardiomyopathy |
| RS547011629 |
LOX
|
Health Risk |
Conflicting classifications of pathogenicity |
LOX-related disorder, LOX-related disorder |
| RS547012639 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Smith-Lemli-Opitz syndrome |
| RS547013163 |
TKFC
|
Health Risk |
Likely pathogenic |
TKFC deficiency, Inborn errors of metabolism |
| RS547014159 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS547014400 |
SPECC1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS547016377 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, Inborn genetic diseases |
| RS547019464 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS547028114 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4C, Susceptibility to mononeuropathy of the median nerve |
| RS547032329 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Familial cold autoinflammatory syndrome 2 |
| RS547034667 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Pituitary adenoma 5 |
| RS547035706 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS547038802 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS547045780 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS547048377 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS547049916 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS547073881 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Inborn genetic diseases |
| RS547076322 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS547080919 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS547085733 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS547088539 |
TNFRSF11A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS547089139 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Inborn genetic diseases |
| RS547099804 |
PROB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS547109690 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS547116063 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Congenital hypothyroidism |
| RS547120028 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS547125345 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ceroid lipofuscinosis, neuronal |
| RS547137141 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 48 |
| RS547142453 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS547147183 |
EPM2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Inborn genetic diseases |
| RS547150342 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS547158013 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS547171686 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Inborn genetic diseases |
| RS547172459 |
KCNE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 6, Cardiovascular phenotype |
| RS547173007 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOG-related disorder, OTOG-related disorder |
| RS547175863 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
PLA2G6-associated neurodegeneration, PLA2G6-associated neurodegeneration |
| RS547175985 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudoxanthoma elasticum, forme fruste |
| RS547177633 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS547184348 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |